AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18492839
Drug: Placebo-supplemented hypoallergenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo-supplemented hypoallergenic formula (8 g/L maltodextrin)
Trial: 15876285
Drug: Twice-daily regimens
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily regimens based on stavudine immediate release or zidovudine
Trial: 7634805
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg i.v. over 30 mins)
Trial: 30919151
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (500 mg levofloxacin without enema)
Trial: 30919151
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (500 mg levofloxacin plus enema)
Trial: 29282143
Drug: Azithromycin (12-month
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (12-month course, weekly)
Trial: 26703278
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac 0.4% (Group A)
Trial: 26703278
Drug: Topical bromfenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bromfenac 0.09% (Group B)
Trial: 26703278
Drug: Topical nepafenac
RxNorm normalized name: Nepafenac
DrugBank: Nepafenac (DB06802)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical nepafenac 0.1% (Group C)
Trial: 23909049
Drug: Atopy patch
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atopy patch tests with aeroallergens (1 x skin prick tests concentration)
Trial: 8491069
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg acetaminophen
Trial: 2663318
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg ibuprofen
Trial: 8388307
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1500 mg/day)
Trial: 3802699
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal plus 75 ml 70% sorbitol
Trial: 22702906
Drug: Elacytarabine 2000
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Elacytarabine 2000 mg/m² per day continuously i.v. during days 1‐5 every 3 weeks
Trial: 11220425
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tenoxicam administered 30 min preoperatively
Trial: 11220425
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg tenoxicam administered at induction of anesthesia
Trial: 8032065
Drug: Sustanon 250
RxNorm normalized name: SUSTAGEN PWDR CHOCOLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustanon 250 (250 mg, 1 ml)
Trial: 29751823
Drug: KENKOJISEICHI group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KENKOJISEICHI group - 90-minute sessions twice per week for 6 months
Trial: 31597690
Drug: Vaccine hesitancy
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine hesitancy screening (15-item PACV survey)
Trial: 27530285
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg droperidol
Trial: 27530285
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg + 10 mg droperidol (repeated at 15 min)
Trial: 14671681
Drug: New formulation
RxNorm normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New formulation of 500 mg ASA and 30 mg PSE
Trial: 14671681
Drug: Preliminary formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preliminary formulation of ASA and PSE
Trial: 8993754
Drug: IMREGR-1 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMREGR-1 treatment
Trial: 6386019
Drug: Preservative-free morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preservative-free morphine 4 mg in saline
Trial: 30782586
Drug: Home treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home treatment of COPD exacerbation
Trial: 30782586
Drug: Hospital treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital treatment for COPD exacerbation
Trial: 23724696
Drug: Acupuncture therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture therapy on PC 6 (Neiguan) and additional acupuncture points (PC 4, HT 7, PC 7, PC 5, PC 3, CV 17, CV 6, BL 15, L 20, BL 17, BL 23, BL 18, HT 5, ST 36)
Trial: 23724696
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug regimen (e.g., Nitroglycerine, Isosorbide mononitrate, Propranolol)
Trial: 6698348
Drug: Cimetidine administration
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine administration
Trial: 27215502
Drug: Indacaterol (IND)
DrugBank: Indacaterol (DB05039)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indacaterol (IND) 75 μg once daily (q.d.)
Trial: 22752776
Drug: Subcutaneous BT088
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous BT088 (200 IU, 0.4 mL)
Trial: 8919896
Drug: Contrast injection
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast injection during the application of 20 cm H2O positive airway pressure for 5 s (Manoeuvre I)
Trial: 8919896
Drug: Contrast injection
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast injection during ventilation with PEEP (15 cm H2O), a tidal volume of 1,200 ml, and a respiratory rate of 6/min (Manoeuvre II)
Trial: 1907075
Drug: Carbohydrate ingestion
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate ingestion (105 grams total in 1050 millilitres solution)
Trial: 21425573
Drug: Integrated medical
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated medical protocol (Chinese medical therapy plus conventional Western medical treatment)
Trial: 21425573
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medical treatment plus placebo
Trial: 20353621
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Group Therapy (CBGT)
Trial: 824298
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg TRH taken twice daily for four weeks
Trial: 824298
Drug: 5-20 mg
RxNorm normalized name: Clinimix 5/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-20 mg TRH taken twice daily for five days
Trial: 26279104
Drug: Transcutaneous PTNS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcutaneous PTNS (voltage pulse intensity of 0 to 10 mA, pulse width of 200 μs, frequency of 20 Hz, 30 min weekly for 12 weeks)
Trial: 26279104
Drug: Sham group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham group (no stimulation, patch electrodes applied)
Trial: 16432272
Drug: Milk thistle
RxNorm normalized name: MILK THISTLE
DrugBank: Milk thistle (DB14375)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk thistle (900 mg) for 14 days
Trial: 16432272
Drug: Black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh (80 mg) for 14 days
Trial: 16432272
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg) for 7 days
Trial: 16432272
Drug: Clarithromycin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (1000 mg) for 7 days
Trial: 1288512
Drug: Bezafibrate (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (600 mg)
Trial: 30862293
Drug: Integrated depression-alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated depression-alcohol misuse cognitive-behaviour therapy (CBT)
Trial: 27756485
Drug: Vaccine (Merck
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine (Merck Adenovirus‐5 Gag/Pol/Nef HIV‐1 subtype‐B vaccine)
Trial: 22307266
Drug: Delayed zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Delayed zoledronic acid (4 mg intravenously every 6 months)
Trial: 10470769
Drug: Change in
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change in ordering practice: No standing orders for routine daily morning chest radiographs; each radiograph requires a written order and clinical indication.
Trial: 2195152
Drug: Toothpaste and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothpaste and oral rinse containing sanguinaria extract and zinc chloride
Trial: 29559771
Drug: FDC of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC of telmisartan 80 mg and S-amlodipine 5 mg (CKD-828)
Trial: 29559771
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of individual agents (telmisartan and S-amlodipine)
Trial: 30036854
Drug: Fingolimod 0.5
RxNorm normalized name: fingolimod 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 0.5 mg/day
Trial: 21067832
Drug: L-citrulline 5.6g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-citrulline 5.6g/day for 7 days
Trial: 9878017
Drug: Drug-containing arms
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug-containing arms of the cultures
Trial: 1957129
Drug: Cefaclor (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (40 mg/kg/day for 7 days)
Trial: 27515877
Drug: Basic oral
RxNorm normalized name: sodium phosphate, dibasic Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic oral care (Control)
Trial: 12236852
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg alone
Trial: 25801058
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg alone
Trial: 9929524
Drug: Coumarin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coumarin (200 mg orally, twice daily for six months)
Trial: 9929524
Drug: Placebo (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (twice daily for six months)
Trial: 2246608
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil diet (10-17 g of n-3 FAs per day)
Trial: 27879460
Drug: Glucantime therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucantime therapy for 1 week after defervescence
Trial: 16418103
Drug: New functional-sexological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New functional-sexological treatment
Trial: 26061132
Drug: Endoscopic thyroidectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic thyroidectomy via oral vestibular approach (ETOVA)
Trial: 19487235
Drug: Bridging from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bridging from oral anticoagulation (OAC) to intravenous heparin infusion (n = 51)
Trial: 19487235
Drug: Maintenance of
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance of oral anticoagulation (OAC) to reach an INR = 2 +/- 0.3 (n = 50)
Trial: 15172900
Drug: Fondaparinux, 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux, 7.5 mg (5.0 mg in patients weighing <50 kg and 10.0 mg in patients weighing >100 kg) subcutaneously once daily
Trial: 9054247
Drug: Lumbar sympathetic
RxNorm normalized name: Bos taurus sympathetic nerve preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar sympathetic nerve block with 10 ml bupivacaine (0.5%)
Trial: 16534653
Drug: Intraarterial chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial chemotherapy (IARC) after potentially curative gastrectomy
Trial: 10686463
Drug: ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ferrous sulfate 325 mg b.i.d.
Trial: 3862158
Drug: Holistic health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Holistic health therapy
Trial: 21355147
Drug: Moxibustion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxibustion therapy
Trial: 26546248
Drug: C-Reactive Protein
RxNorm normalized name: C-reactive protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-Reactive Protein (CRP) levels >2 mg/L
Trial: 24112375
Drug: Diet+IDet (Insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet+IDet (Insulin detemir with dietary intervention)
Trial: 24112375
Drug: IDet (Insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDet (Insulin detemir alone)
Trial: 17243612
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amlodipine and verapamil retard
Trial: 14671204
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg dexamethasone twice daily for 6 days
Trial: 3462013
Drug: Cladosporium herbarum
RxNorm normalized name: CLADOSPORIUM HERBARUM
DrugBank: Cladosporium herbarum (DB10865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladosporium herbarum inhalation (concentrations: 1:100000, 1:10000, 1:1000, 1:100)
Trial: 3462013
Drug: Histamine inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine inhalation (concentrations: 0.3, 0.6, 1.2, 2.4 mg/ml)
Trial: 3462014
Drug: Cladosporium herbarum
RxNorm normalized name: CLADOSPORIUM HERBARUM
DrugBank: Cladosporium herbarum (DB10865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladosporium herbarum inhalation
Trial: 23866410
Drug: Once-daily tadalafil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily tadalafil (10mg)
Trial: 18088349
Drug: TTP889 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TTP889 (300 mg once daily)
Trial: 12449522
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus droperidol (3 mg granisetron and 1.25 mg droperidol)
Trial: 9887116
Drug: Flavored water
RxNorm normalized name: FLAVOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavored water plus 6% carbohydrate and 18 mmol/l Na (CNa)
Trial: 2039639
Drug: Continuous alfentanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous alfentanil infusion (100 micrograms/kg bolus followed by continuous infusion)
Trial: 24535759
Drug: Cryolipolysis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryolipolysis treatment on the flank
Trial: 23769296
Drug: 45 mg
RxNorm normalized name: lutein 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 45 mg ustekinumab
Trial: 23769296
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg ustekinumab
Trial: 18972276
Drug: Budesonide/formoterol (320/9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (320/9 microg 4 times daily)
Trial: 16649833
Drug: Adherence with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence with antipsychotic medication
Trial: 27116024
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of ciprofloxacin
Trial: 20400095
Drug: Middle-dose eplerenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Middle-dose eplerenone (25 mg twice daily)
Trial: 6483504
Drug: DL-carnitine, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL-carnitine, 100 mg/kg/day for 4 days
Trial: 28549895
Drug: Needle-free jet
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-free jet lidocaine (J-tip) administration (0.25 mL of 2% lidocaine)
Trial: 28549895
Drug: Simultaneous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simultaneous lidocaine injection (0.5 mL of 1% lidocaine) with corticosteroid
Trial: 24104763
Drug: Target-controlled infusion
RxNorm normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Target-controlled infusion (TCI) of propofol 10 mg/mL, initial targeted effect-site concentration 2 μg/mL
Trial: 24104763
Drug: Patient-controlled sedation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled sedation (PCS) of propofol, single bolus 1 mL, lockout time set at zero
Trial: 1335642
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses at days 0 and 28 (group 4)
Trial: 1335642
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses at days 0, 7 and 21 (group 5)
Trial: 23218817
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate 0.5% gel
Trial: 26020827
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate 1% solution
Trial: 24320999
Drug: Zumba training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zumba training (twice a week for 8 weeks)
Trial: 21669534
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 0.5% plain bupivacaine
Trial: 21669534
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml normal saline (Control)
Trial: 26976091
Drug: Escitalopram, 10
RxNorm normalized name: Escitalopram, 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram, 10 mg/7 days
Trial: 16918728
Drug: Intragastric saline-intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric saline-intravenous motilin infusion
Trial: 16918728
Drug: Intragastric acid-intravenous
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAGASTRIC LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric acid-intravenous motilin infusion
Trial: 16918728
Drug: Intragastric saline-intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric saline-intravenous motilin infusion and intragastric acid-intravenous saline infusion
Trial: 16918728
Drug: Control (intragastric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (intragastric saline-intravenous saline)
Trial: 15579527
Drug: Tapering of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering of prednisolone (TAP) from 16 mg (range 10 to 30) to 9 mg (range 5 to 12.5) daily
Trial: 15579527
Drug: Steroid withdrawal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid withdrawal (SW) of 5 mg prednisolone
Trial: 10081698
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no preoperative therapy)
Trial: 3517560
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg BAY o1248
Trial: 16206505
Drug: BCAA (branched-chain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA (branched-chain amino acid) granules at 12 g/day for 2 years
Trial: 16206505
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy with defined daily food intake (1.0-1.4 g protein kg(‐1) day(‐1) including BCAA preparation and 25-35 kcal kg(‐1) day(‐1))
Trial: 11996327
Drug: Fiduxosin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiduxosin (30 mg) under nonfasting conditions
Trial: 11996327
Drug: Fiduxosin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fiduxosin (30 mg) under fasting conditions
Trial: 2027271
Drug: Gastric-coated calcium
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric-coated calcium carbonate (3.1-3.6 g/d)
Trial: 2027271
Drug: Aluminium hydroxide
RxNorm normalized name: Aluminium hydroxide
DrugBank: Aluminum hydroxide (DB06723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminium hydroxide (2.9 g/d)
Trial: 2027271
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (3.1-3.6 g/d)
Trial: 17050010
Drug: Intracoronary stem
RxNorm normalized name: stem bromelain
DrugBank: Stem bromelain (DB12249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary stem cell therapy
Trial: 24176222
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin 750 mg twice daily